Free Trial
NASDAQ:GUTS

Fractyl Health (GUTS) Stock Price, News & Analysis

Fractyl Health logo
$1.01 -0.86 (-45.99%)
Closing price 08/6/2025 04:00 PM Eastern
Extended Trading
$1.00 -0.02 (-1.49%)
As of 08/6/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Fractyl Health Stock (NASDAQ:GUTS)

Key Stats

Today's Range
$0.83
$1.05
50-Day Range
$1.49
$2.88
52-Week Range
$0.83
$3.72
Volume
8.81 million shs
Average Volume
458,549 shs
Market Capitalization
$49.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00
Consensus Rating
Buy

Company Overview

Fractyl Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

GUTS MarketRank™: 

Fractyl Health scored higher than 47% of companies evaluated by MarketBeat, and ranked 1458th out of 1,841 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Fractyl Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Fractyl Health has received no research coverage in the past 90 days.

  • Read more about Fractyl Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Fractyl Health are expected to decrease in the coming year, from ($1.61) to ($1.81) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fractyl Health is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fractyl Health is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Fractyl Health has a P/B Ratio of 1.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Fractyl Health's valuation and earnings.
  • Percentage of Shares Shorted

    9.05% of the float of Fractyl Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Fractyl Health has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Fractyl Health has recently decreased by 7.35%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Fractyl Health does not currently pay a dividend.

  • Dividend Growth

    Fractyl Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.05% of the float of Fractyl Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Fractyl Health has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Fractyl Health has recently decreased by 7.35%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Fractyl Health has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Fractyl Health this week, compared to 2 articles on an average week.
  • Search Interest

    7 people have searched for GUTS on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Fractyl Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
Receive GUTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fractyl Health and its competitors with MarketBeat's FREE daily newsletter.

GUTS Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
Fractyl Health Announces Proposed Public Offering
Fractyl Health: Speculative Buy With Binary Risk
See More Headlines

GUTS Stock Analysis - Frequently Asked Questions

Fractyl Health's stock was trading at $2.06 at the beginning of the year. Since then, GUTS stock has decreased by 51.0% and is now trading at $1.01.

Fractyl Health, Inc. (NASDAQ:GUTS) issued its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.49) EPS for the quarter, meeting the consensus estimate of ($0.49). Fractyl Health had a negative trailing twelve-month return on equity of 228.66% and a negative net margin of 73,864.52%.
Read the conference call transcript
.

Fractyl Health (GUTS) raised $110 million in an initial public offering on Friday, February 2nd 2024. The company issued 7,333,333 shares at $15.00 per share.

Top institutional investors of Fractyl Health include Y Intercept Hong Kong Ltd (0.23%). Insiders that own company stock include Ajay Royan, Harith Rajagopalan, Jay David Caplan and William Bradley.
View institutional ownership trends
.

Shares of GUTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fractyl Health investors own include SoFi Technologies (SOFI), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Alphabet (GOOG), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
5/13/2025
Today
8/07/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:GUTS
Previous Symbol
NASDAQ:GUTS
CIK
1572616
Fax
N/A
Employees
102
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$10.00
Potential Upside/Downside
+989.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.85)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$68.69 million
Net Margins
-73,864.52%
Pretax Margin
-148,511.67%
Return on Equity
-228.66%
Return on Assets
-76.74%

Debt

Debt-to-Equity Ratio
4.61
Current Ratio
2.50
Quick Ratio
2.50

Sales & Book Value

Annual Sales
$60 thousand
Price / Sales
824.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.59 per share
Price / Book
1.71

Miscellaneous

Outstanding Shares
48,977,000
Free Float
N/A
Market Cap
$49.47 million
Optionable
N/A
Beta
1.66

Social Links

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:GUTS) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners